Frazor Edmondson
Vermogen: 538 587 $ op 31-05-2026
Vermogen: 538 587 $ op 31-05-2026
Frazor Titus Edmondson currently works at Zai Lab Ltd., as Secretary & Chief Legal Officer from 2025.
Mr. Edmondson also formerly worked at Sumitomo Pharma America, Inc., as Secretary, Associate General Counsel & VP and Biogen, Inc., as Chief Corporation Counsel & Senior Vice President from 2014 to 2020.
Mr. Edmondson received his undergraduate degree in 1988 from Washington & Lee University and graduate degree in 1993 from Widener University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZAI LAB LTD. 0,03% | 26-06-2026 | 303.460 ( 0,03% ) | 538 587 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ZAI LAB LIMITED | Algemeen Adviseur | 07-08-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-08-2020 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Bedrijfssecretaris | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Widener University School of Law
Widener University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau